Search

everythinglearnresearchcommunity

for

Search:↓

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Protein analysis shows aging changes in scalp cell types from women.

Skin aging and cancer development are influenced by the competition between stem cells.

Low oxygen levels affect the behavior of certain proteins in human skin cells.

Human-induced stem cell-created skin models can help understand skin diseases by studying the skin's layers.

COVID-19 can cause various skin symptoms that usually improve with proper treatment.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

Psoriasis treatments don't raise severe COVID-19 risk, except for acitretin.

Some COVID-19 patients have different skin problems, which might be the only sign of the virus or related to other health issues.

COVID-19 can cause skin problems directly or from using protective gear and sanitizers, and knowing this can help treat patients better.

Insulin resistance linked to obesity may increase COVID-19 severity.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

COVID-19 and its vaccines can cause various skin issues, with urticaria being the most common.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

AGA might indicate higher risk for severe COVID-19.

Face mask-related injuries in U.S. emergency departments rose by 2400% during the COVID-19 pandemic, with most injuries being dermatitis and lacerations.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

COVID-19 affects multiple body systems and complicates treatment; accurate testing is crucial.

Skin symptoms linked to COVID-19 are hard to confirm, and more testing is needed to identify which are truly caused by the virus.

A COVID-19 patient had unusual nail discoloration and nail separation possibly due to the virus's effects on small blood vessels.

The research found that COVID-19 survivors experienced long-term effects like anemia and hypertension, with age and gender being important factors, but race, income, and education had little to no impact.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

People with blood group O may have a higher risk of developing post-COVID-19 syndrome.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.